![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach:
Dokumententyp
| Veröffentlichungsdatum
Springe zu: Zeitschriftenartikel
Anzahl der Publikationen: 8
Zeitschriftenartikel
Jin, Xi-Feng; Spöttl, Gerald; Maurer, Julian; Nölting, Svenja und Auernhammer, Christoph Josef
(2021):
Antitumoral Activity of the MEK Inhibitor Trametinib (TMT212) Alone and in Combination with the CDK4/6 Inhibitor Ribociclib (LEE011) in Neuroendocrine Tumor Cells In Vitro.
In: Cancers, Bd. 13, Nr. 6, 1485
Fankhauser, Maria; Bechmann, Nicole; Lauseker, Michael; Goncalves, Judith; Favier, Judith; Klink, Barbara; William, Doreen; Gieldon, Laura; Maurer, Julian; Spöttl, Gerald; Rank, Petra; Knösel, Thomas; Orth, Michael; Ziegler, Christian G.; Aristizabal Prada, Elke Tatjana; Rubinstein, German; Fassnacht, Martin; Spitzweg, Christine; Grossman, Ashley B.; Pacak, Karel; Beuschlein, Felix; Bornstein, Stefan R.; Eisenhofer, Graeme; Auernhammer, Christoph J.; Reincke, Martin und Nölting, Svenja
(2019):
Synergistic Highly Potent Targeted Drug Combinations in different Pheochromocytoma Models including Human Tumor Cultures.
In: Endocrinology, Bd. 160, Nr. 11: S. 2600-2617
Aristizabal Prada, Elke Tatjana; Weis, Carla; Orth, Michael; Lauseker, Michael; Spöttl, Gerald; Maurer, Julian; Grabowski, Patricia; Grossman, Ashley; Auernhammer, Christoph Josef und Nölting, Svenja
(2. Oktober 2018):
GSK3α/β: A Novel Therapeutic Target for Neuroendocrine Tumors?
In: Neuroendocrinology, Bd. 106, Nr. 4: S. 335-351
Aristizabal Prada, Elke Tatjana; Spöttl, Gerald; Maurer, Julian; Lauseker, Michael; Koziolek, Eva Jolanthe; Schrader, Jörg; Grossman, Ashley; Pacak, Karel; Beuschlein, Felix; Auernhammer, Christoph Joseph und Nölting, Svenja
(2018):
The role of GSK3 and its reversal with GSK3 antagonism in everolimus resistance.
In: Endocrine-Related Cancer, Bd. 25, Nr. 10: S. 893-908
Prada, Elke Tatjana Aristizabal; Orth, Michael; Nölting, Svenja; Spöttl, Gerald; Maurer, Julian und Auernhammer, Christoph
(2017):
The MTH1 inhibitor TH588 demonstrates anti-tumoral effects alone and in combination with everolimus, 5-FU and gamma-irradiation in neuroendocrine tumor cells.
In: PLOS One 12(5), e0178375 [PDF, 15MB]
In: PLOS One 12(5), e0178375 [PDF, 15MB]
Reuther, Clemens; Heinzle, Vera; Spampatti, Matilde; Vlotides, George; De Toni, Enrico; Spöttl, Gerald; Maurer, Julian; Nölting, Svenja; Göke, Burkhard und Auernhammer, Christoph J.
(2016):
Cabozantinib and Tivantinib, but Not INC280, Induce Antiproliferative and Antimigratory Effects in Human Neuroendocrine Tumor Cells in vitro: Evidence for 'Off-Target' Effects Not Mediated by c-Met Inhibition.
In: Neuroendocrinology, Bd. 103, Nr. 3-4: S. 383-401
[PDF, 916kB]
Berger, Peter; Schwarz, Siegfried; Spöttl, Gerald; Wick, Georg und Mann, Klaus
(1993):
Variants of human chorionic gonadotropin from pregnant women and tumor patients recognized by monoclonal antibodies.
In: The Journal of Clinical Endocrinology & Metabolism, Bd. 77, Nr. 2: S. 347-351
[PDF, 1MB]
Hörmann, Rudolf; Gerbes, Alexander L.; Spöttl, Gerald; Jüngst, Dieter und Mann, Klaus
(1992):
Immunoreactive human chorionic gonadotropin and its free ß-subunit in serum and ascites of patients with malignant tumors.
In: Cancer research, Bd. 52: S. 1520-1524
[PDF, 1MB]